Arvinas Inc
2 nominees · 3 ballot items.
Elect two Class II directors; approve, on a non-binding advisory basis, the compensation of the named executive officers (say-on-pay); and ratify Deloitte & Touche LLP as the company’s independent registered public accounting firm for 2026.
Follow how the vote landed and what changed on Arvinas Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of two Class II directors
ManagementBoard: FORElection of two Class II directors — Leslie V. Norwalk, Esq. and Randy Teel, Ph.D., each to serve a three-year term expiring at the 2029 annual meeting.
- 2
Advisory vote on executive compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation paid to the company’s named executive officers as disclosed in the proxy statement, including the Compensation Discussion and Analysis and compensation tables.
More detail
This non-binding "say-on-pay" proposal asks shareholders to approve, on an advisory basis, the compensation paid to the company’s named executive officers as disclosed in the proxy statement, including the Compensation Discussion and Analysis and compensation tables. Management seeks this advisory endorsement to validate its pay-for-performance approach, which ties significant compensation to long‑term equity and corporate goal achievement and is intended to align executive incentives with stockholder value creation. The proxy explains the components of pay (base salary, annual cash bonus based on corporate goals, and long‑term equity in Options and RSUs) and describes recent actions by the compensation committee, including annual merit increases, one-time retention awards in 2025, and an annual equity grant mix intended to balance retention and upside. The filing provides important context: a recent VERITAC-2 Phase 3 readout that disappointed investors drove a significant stock-price decline and prompted heightened stockholder engagement; management reports that the 2025 say-on-pay received roughly 75% support and that the board and compensation committee engaged with large institutional holders afterward. In response to stockholder feedback, the company adjusted its practices (reducing 2026 annual equity grant sizes for senior roles, implementing workforce reductions and cost actions, initiating a share repurchase program and committing to continued engagement). The board frames the advisory vote as an important indicator — non-binding but considered when setting future pay — and recommends a FOR vote because it believes the program aligns incentives, supports retention and is consistent with market practices. Risk-mitigation features cited include equity mix (Options plus RSUs), annual bonus calibration tied to corporate goals, clawback policy, independent compensation committee and use of an independent compensation consultant. Given the non-binding nature of the vote, the outcome will not change contractual obligations but will guide future compensation decisions and governance actions by the board and compensation committee.
- 3
Ratification of the appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026
ManagementBoard: FORRatify Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Nominees on the ballot2
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.0% | 3,889,628 | $41M |
| 2 | PFIZER INC | 5.4% | 3,457,815 | $35M |
| 3 | D. E. Shaw Co., Inc.Activist | 5.0% | 3,257,217 | $35M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 2,689,362 | $29M |
| 5 | BlackRock, Inc. | 4.1% | 2,614,815 | $28M |
| 6 | BlackRock, Inc. | 3.8% | 2,420,192 | $26M |
| 7 | TCG Crossover Management, LLC | 3.7% | 2,387,461 | $25M |
| 8 | ARMISTICE CAPITAL, LLC | 3.1% | 1,978,000 | $21M |
| 9 | TWO SIGMA INVESTMENTS, LP | 2.8% | 1,832,114 | $19M |
| 10 | STATE STREET CORP | 2.8% | 1,828,472 | $19M |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Arvinas Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Arvinas Inc 2026 annual meeting?
- Arvinas Inc (ARVN) holds its 2026 annual shareholder meeting on Wednesday, June 24, 2026.
- What is the record date for the Arvinas Inc 2026 meeting?
- The record date for the Arvinas Inc 2026 meeting is Monday, April 27, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Arvinas Inc's 2026 meeting?
- The board is presenting 2 director nominees at the Arvinas Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Arvinas Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Arvinas Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.